Is Gemina Laboratories Ltd. (GLABF) a Buy, Sell, or Hold?
OTC : GLABF
Gemina Laboratories Ltd.
$0.05 USD
$0 (0.0%)
- Volume
- 244K
- Average Volume
- 216.89K
- Market Capitalization
- $3.83M
- P/E Ratio
- -1.54
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.55
- Year Low
- $0.04
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.01
Company Overview
OTC
Robert Crandall Greene
Biotechnology
Healthcare
GLABF
6
CA
USD
Liquidity Metrics
-0.05
0.01
0.01
0.00
0.00
Sales & Valuation
$21502
422.34
-0.89
7853.43
0.00
Profitability
-$0.0307
-$2.34M
-26928.44%
-26928.44%
62.39%
-263.70%
P/E Metrics
-1.54
-0.16
-0.16
Analyst Price Target & Rating
2/5
0 Analysts
%
Financial Health Scores
-29.17
4/9
-$7.04M
$1.62M
$7.6M
-$2.15M
Key Metrics (TTM)
$4.83M
444.47
-1.74
0.01
62.39%
57.93%
-63.76%
0.01%
-18466 days
Company Executives
| Name | Title |
|---|---|
| Robert Crandall Greene | Chief Executive Officer & Director |
| Christine Buerki | Head of Research & Development |
Poll Results
No votes yet today — be the first to share your view!
About Gemina Laboratories Ltd. (OTC:GLABF) Stock
Gemina Laboratories Ltd. is a Canadian biotechnology enterprise primarily focused on the investigation, creation, and commercialization of in vitro diagnostic solutions. The firm's innovation extends to developing unique surface functionalization chemistries specifically designed for the identification of pathogens and various biological markers. A significant ongoing project is the POC Antigen COVID test, a rapid, point-of-care lateral flow assay strip intended to determine active COVID-19 infections. The company maintains its corporate headquarters in Vancouver, Canada. ...
Frequently Asked Questions
-
What is the current Gemina Laboratories Ltd. (GLABF) stock price?
-
Gemina Laboratories Ltd.(OTC:GLABF) stock price is $0.05 in the last trading session. During the trading session, GLABF stock reached the peak price of $0.55 while $0.0375 was the lowest point it dropped to. The percentage change in GLABF stock occurred in the recent session was 0.0% while the dollar amount for the price change in GLABF stock was $0.
-
GLABF's industry and sector of operation?
-
The OTC listed GLABF is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of GLABF?
-
Robert Crandall Greene | Chief Executive Officer & Director
Christine Buerki | Head of Research & Development
|
|
| -
How many employees does GLABF have?
-
Number of GLABF employees currently stands at 6. GLABF operates from 3800 Westbrook Mall, Burnaby, BC V5G 4W8, CA.
-
Link for GLABF official website?
-
Official Website of GLABF is: https://www.geminalabs.com
-
How do I contact GLABF?
-
GLABF could be contacted at phone #604-760-1997 and can also be accessed through its website. GLABF operates from 3800 Westbrook Mall, Burnaby, BC V5G 4W8, CA.
-
How many shares of GLABF are traded daily?
-
The average number of GLABF shares traded daily for last 3 months was 216.89K.
-
What is the market cap of GLABF currently?
-
The market value of GLABF currently stands at $3.83M with its latest stock price at $0.05